Janux Therapeutics Inc (JANX) stock news · rev $10.0M
Janux Therapeutics Inc (JANX) is a biotechnology company listed on US.
This JANX news page leads with what Janux Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for JANX yet. We will not pad this page with generic market recap.
Latest reported JANX revenue for 2025-12-31 was $10.0M. Net income was -$113.6M. Revenue was down 5.6% from 2024-12-31 to 2025-12-31. JANX currently screens at market cap $1.49B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the JANX stock page; for the tape open the quote page.
JANX stock news FAQ
What are JANX's latest revenue and net income?
Latest cached Janux Therapeutics Inc (JANX) revenue for Dec 31, 2025 was $10.0M. Net income was -$113.6M. Statements: https://lician.com/financials/janx
How did JANX revenue change from the prior cached period?
Cached Janux Therapeutics Inc (JANX) revenue was down 5.6% from $10.6M (Dec 31, 2024) to $10.0M (Dec 31, 2025). Statements: https://lician.com/financials/janx
What is JANX's market cap?
Janux Therapeutics Inc (JANX) market cap is $1.49B on the latest cached fundamentals snapshot.
What kind of company is JANX?
Janux Therapeutics Inc (JANX) is a biotechnology company listed on US.
Where is JANX stock news listed?
Cached stock news for Janux Therapeutics Inc (JANX) is listed at https://lician.com/news/janx. Filings: https://lician.com/sec/janx
Not investment advice.